Avita Medical | 1811094D - Ebitda

Aktienkurs
1.13
Täglich Wechseln
-0.04 -3.42%
Monatlich
-11.37%
Jährlich
-61.30%
Q1 Prognose
1.23




Ebitda Veränderung Datum
Accuray USD -685K 900K 2024-09
Celltrion KRW 374.56B 352.67B 2025-09
Clinuvel Pharmaceuticals AUD 27.55M 12.65M 2025-06
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Mayne Pharma AUD 20.9M 5.2M 2025-06
Medical Developments International AUD 1.78M 3.78M 2024-12
Nanosonics AUD 12.49M 1.13M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
Pharma Mar EUR 44.96M 46.94M 2025-12
Polynovo AUD 3.89M 100K 2025-12
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Sartorius EUR 277.4M 30.5M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06